Cytokinetics IncCYTK
Price$65.62

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $67.7M+266.3% YoYTTM through 30 Jun 2026
Net Income -$894MTTM through 30 Jun 2026
Free Cash Flow -$580.7MTTM through 30 Jun 2026

Margins

Current
Gross Margin86.6%
Operating Margin-946.4%
Net Margin-1,321.1%

Returns

-46.5%ROA

Balance Sheet Health

Debt / Equity-1.57x
Current Ratio3.99x
Net Debt$481.5M
Cash & Equivalents$255.3M

Quality Metrics

Altman Z-Score-0.68
Piotroski F-Score4 / 9
FCF Margin-858.2%
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $88M
Diluted EPS-$7.22TTM
'17'20'21'22'23'24'25
FY2025: $-6,536.00

Dividend

No dividend

Capital Allocation

Capex Intensity37.3%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.